Gene Logic Signs Licensing, Research Agreements with Millennium; Reports Falling Revenues in Q2 | GenomeWeb

NEW YORK, July 23 (GenomeWeb News) - Gene Logic today reported falling revenues and a slightly increased net loss for the second quarter of the year. The company also announced a broad technology cross-licensing agreement with Millennium Pharmaceuticals, based on which it will offer a new research service. Millennium, which licensed Gene Logic's ToxExpress database, will be the first customer for the service.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.